Virtual Incision
- 20/09/2023
- Series C
- $30,000,000
Virtual Incision is on a mission to simplify robotic-assisted surgery (RAS), so more patients and their surgeons can access its benefits every day.
Headquartered in Lincoln, Nebraska, and holding over 200 patents and patent applications, the company is developing MIRA, the first-of-its-kind miniature, and highly accessible RAS platform. With MIRA, our goal is to make every operating room RAS-ready.
MIRA is currently in FDA clinical trials under an Investigational Device Exemption (IDE) and is being studied first for bowel resection, with additional potential applications to follow.
https://virtualincision.com
- Industry Medical Equipment Manufacturing
- Website https://virtualincision.com/
- LinkedIn https://www.linkedin.com/company/virtual-incision-corporation/about/
Related People
John MurphyFounder
Customer-focused global operating exec in Surgical Robotics, Medical Devices, Medical Imaging, Life Science Tools & Diagnostics, Optoelectronics, Technology and Aerospace. Public, Private Equity and Venture Capital environments.